Pascal Biosciences Inc. (TSXV:PAS), a biotech stock, climbed after announcing that it has discovered certain cannabinoids that enhance the immunogenicity of tumor cells
A cannabinoid research discovery provided healthy returns for a biotech stock Wednesday. Here’s some small stocks making big moves on Wednesday, February 21, 2018 (as of 4 pm EST):
Pascal Biosciences Inc. (TSXV:PAS), a biotech stock, jumped 260% to $0.72 on Wednesday after announcing that it has discovered certain cannabinoids that enhance the immunogenicity of tumor cells, rendering them more susceptible to recognition by the immune system.
As well, shares of RYU Apparel Inc. (TSXV:RYU) slipped 12% to $0.22 as the creator of urban athletic apparel said it has secured its first Californian location on Abbot Kinney Boulevard, in Venice Beach, California.
Altamira Gold Corp. (TSXV:ALTA), meanwhile, reported that it has begun an exploration program for concealed porphyry copper mineralization throughout the Juruena Belt of Mato Grosso state in Brazil. Altamira Gold stock popped 33% to $0.24 following the announcement.
Finally, EnerDynamic Hybrid Technologies Corp. (TSXV:EHT) shares rose 6% to $0.09 after the sustainable energy solutions provider announced that its joint venture with Groupe Nduom has begun sales and distribution of Solar Panels and Solar Systems in Ghana.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Pascal Biosciences Inc. (TSXV:PAS), a biotech stock, jumped 260% to $0.72 on Wednesday after announcing that it has discovered certain cannabinoids that enhance the immunogenicity of tumor cells, rendering them more susceptible to recognition by the immune system.
